Featured Research

from universities, journals, and other organizations

New Target To Combat Cancer? Defects In Pathway Underlying Fanconi Anaemia Can Cause Cancer In Non-FA Patients

Date:
May 20, 2009
Source:
NWO (Netherlands Organization for Scientific Research)
Summary:
In patients with Fanconi anaemia (FA), one of the DNA repair mechanisms that normally protects us against cancer no longer works adequately. A Dutch researcher set out to find the genes responsible for this defect. He discovered a new FA gene and established that FA gene defects could also cause cancer in people who do not suffer from FA. Although this does not sound positive, it is in fact good news. That is because cells with a FA defect are hypersensitive to certain types of chemotherapy and can therefore be specifically targeted.

In patients with Fanconi anaemia (FA) one of the DNA repair mechanisms that normally protects us against cancer no longer works adequately. Dutch researcher Najim Ameziane set out to find the genes responsible for this defect. He discovered a new FA gene and established that FA gene defects could also cause cancer in people who do not suffer from FA. Although this does not sound positive, it is in fact good news. That is because cells with a FA defect are hypersensitive to certain types of chemotherapy and can therefore be specifically targeted.

Related Articles


DNA is continuously damaged. This is normally not a problem because our proteins repair the damaged DNA. However, in patients with FA that is a different story. They have a congenital defect as a result of which the DNA is not repaired. Therefore errors accumulate. These errors can result in uncontrolled cell division. Many patients are therefore confronted with cancer at an early age.

Thirteen different genes, including the well-known breast cancer gene BRCA2, can cause FA if any one of these is defective. These thirteen genes code for proteins that function in a biochemical pathway, the so-called Fanconi anaemia (FA) pathway, to repair the DNA. FA patients have a defect in one of these 13 proteins, as a result of which the pathway no longer functions and they run a high risk of developing cancer. However, now the question is whether errors in this pathway can also cause cancer in patients without FA.

Targeted treatment

To determine whether errors in the FA pathway in people without FA can cause cancer, all of the genes involved in that pathway need to be identified. Before Ameziane started his PhD research, only eight of the genes in the pathway had been identified. Now thirteen genes are known and there are strong indications that even more genes are involved. During his analysis of genetic material from FA patients, the researcher discovered one of the new genes that constitute part of the FA pathway. This gene, just like BRCA2, appears to be responsible for an increased risk of breast cancer.

The discovery of new genes enables researchers to gain a better understanding of how a defect in the FA pathway can cause cancer, even in people without FA. Ameziane's research has now revealed that a subtype of certain forms of cancer does indeed have a defect in the FA pathway. Ameziane discovered this whilst investigating tumour material from people without FA.

Although the role of genes in the FA pathway has not been fully clarified with this discovery, the discovery nevertheless gives hope for a more targeted approach to certain forms of cancer. That is because cells with a FA pathway defect are hypersensitive to certain drugs that are used during chemotherapy. Cancers that are caused by a FA defect can therefore be treated in a more targeted manner. Moreover, the study of the rare and incurable disease FA may provide insights into how cancer develops.

Najim Ameziane received a NWO Mosaic grant in 2004 for his PhD research. With this individual grant, NWO tries to encourage more people from ethnic minorities to carry out PhD research. Ameziane hopes to be able to continue his research as a post-doc.


Story Source:

The above story is based on materials provided by NWO (Netherlands Organization for Scientific Research). Note: Materials may be edited for content and length.


Cite This Page:

NWO (Netherlands Organization for Scientific Research). "New Target To Combat Cancer? Defects In Pathway Underlying Fanconi Anaemia Can Cause Cancer In Non-FA Patients." ScienceDaily. ScienceDaily, 20 May 2009. <www.sciencedaily.com/releases/2009/05/090514084119.htm>.
NWO (Netherlands Organization for Scientific Research). (2009, May 20). New Target To Combat Cancer? Defects In Pathway Underlying Fanconi Anaemia Can Cause Cancer In Non-FA Patients. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2009/05/090514084119.htm
NWO (Netherlands Organization for Scientific Research). "New Target To Combat Cancer? Defects In Pathway Underlying Fanconi Anaemia Can Cause Cancer In Non-FA Patients." ScienceDaily. www.sciencedaily.com/releases/2009/05/090514084119.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins